Vidullanka in private placement deal to purchase Ugandan hydro power plant

2017-03-01 10:27:50

Vidullanka PLC (VLL), a mini hydro operator said it was carrying out a private placement of shares to partly settle the purchase of a mini hydro project in Uganda, subject to Colombo Stock Exchange and shareholder approval. 
The company expects to issue a maximum of 10 million shares to Timex Garments (Pvt) Ltd., to raise Rs.50 million. The share issue would result in a 3.9 percent increase in VLL’s stated capital and a maximum of 1.34 percent increase in the number of shares in issue.

The current stated capital of VLL stands at Rs.1.23 billion.
The Ugandan mini hydro, Timex Bukinda Hydro (U) Limited, is yet to sign a standard power purchasing agreement with Ugandan authorities for the development of 6.5 mega watt   Bukinda Smalll Hydro Power plant.
However, VLL said all other necessary studies and approvals have already been secured. This is not the first time VLL is carrying out a private placement of shares to fund an acquisition.
In 2015, the company issued 31.25 million shares by way of a share swap to Jaywise Construction (Pvt) Ltd., to partly fund the acquisition of Lower Kotmale Oya Hydro Power plant. 


  Comments - 0

Add comment

Comments will be edited (grammar, spelling and slang) and authorized at the discretion of Daily Mirror online. The website also has the right not to publish selected comments.
Name is required

Email is required
Comment cannot be empty

eMarketingEye wins “Best Digital Media Agency” in Travel and Leisure Sector

Tuesday, 15 January 2019 13:58

eMarketingEye (, the award-winning Sri Lankan Digital Marketing Agency and a p

Sampath Bank Moves Kochchikade Branch to New Location

Tuesday, 15 January 2019 13:53

Sampath Bankre located its Kochchikade Branch to a more spacious and easy to access premises located

NMRA together with Epic Technology Group launch Phase 1 of Document and Workflow Management System

Tuesday, 15 January 2019 13:43

The first phase of the digitalization project of the National Medicines Regulatory Authority was lau

More News